Pfizer launches pilot delivery programme for its coronavirus vaccine
November 17, 2020Manufacturing and Production
Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be …
UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy
November 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine
US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year
November 16, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen
November 16, 2020Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine
Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …
British Labour Party calls for new laws to tackle online anti-vaxx campaigns
November 16, 2020Sales and Marketing
The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet …
Antidepressants could treat coronavirus, new study suggests
November 16, 2020Sales and Marketing
The antidepressant fluvoxamine could treat COVID-19 patients and stop their symptoms from worsening, according to a new study.
UK Prime Minister Boris Johnson self-isolating after meeting an MP who had COVID-19
November 16, 2020Sales and Marketing
The British Prime Minister Boris Johnson has begun working in self isolation after coming into contact with an MP who …
Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine
November 13, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel
Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …
Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role
November 13, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma
Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
India preparing 100 million doses of AstraZeneca’s COVID-19 vaccine for inoculation programme
November 13, 2020Medical Communications
India is aiming to have 100 million doses of AstraZeneca’s COVID-19 vaccine ready for an inoculation drive beginning next month. …
World Health Organization to set up traditional medicines centre in India
November 13, 2020Medical Communications
The World Health Organization announced today that it will set up the Global Centre for Traditional Medicine in India. General …
Top Ten most popular articles on Pharmafile.com this week
November 13, 2020Medical Communications
The top ten news stories this week focus on COVID-19 vaccines, with clinical trial participants who received the Pfizer/BioNTech coronavirus …
AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients
November 12, 2020Business Services AZ, AstraZeneca, Calquence
AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19. Calquence (acalabrutinib) is …
NICE recommends Sanofi’s Cablivi for ultra-rare acute thrombotic thrombocytopenic purpura
November 12, 2020Sales and Marketing NHS, NICE, Sanofi, pharma
Sanofi’s Cablivi (caplacizumab) has received recommendation from NICE for routine NHS use in England and Wales for the treatment of …
Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data
November 12, 2020Sales and Marketing COVID-19, Pfizer, Vaccine, pharma
With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …
COVID-19 increases the risk of developing psychiatric disorders, new study says
November 12, 2020Business Services
People who are infected with COVID-19 are at higher risk of developing depression, insomnia and anxiety for the first time, …
Pfizer/BioNTech vaccine side effects feel like a “severe hangover”
November 12, 2020Business Services COVID, Vaccine, coronavirus
Clinical trial participants receiving the Pfizer/BioNTech coronavirus vaccine have said it created side effects that felt similar to a “severe …
First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine
November 11, 2020Research and Development COVID-19, Russia, Sputnik V, Vaccine
The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …
Head of UK vaccine taskforce grilled over government investment into her private equity firm
November 11, 2020Research and Development COVID, UK COVID, coronavirus
Kate Bingham, the Head of the British Government’s vaccine taskforce, is facing further questions over a conflict of interest as …
CureVac’s COVID-19 vaccine generates immune responses at Phase 1
November 11, 2020Research and Development COVID-19, CureVac, pharma
German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
